Tilray Inc (NASDAQ:TLRY - Get Free Report) shares were down 6.1% during trading on Friday . The company traded as low as $1.97 and last traded at $1.99. Approximately 28,616,737 shares traded hands during mid-day trading, a decline of 8% from the average daily volume of 31,063,402 shares. The stock had previously closed at $2.12.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on TLRY. CIBC reduced their price objective on Tilray from $2.25 to $2.00 and set a "neutral" rating for the company in a report on Wednesday, April 10th. Canaccord Genuity Group decreased their price objective on Tilray from $4.25 to $4.00 and set a "buy" rating on the stock in a report on Wednesday, April 10th. Finally, Alliance Global Partners lifted their target price on Tilray from $2.25 to $2.75 and gave the stock a "neutral" rating in a report on Friday, April 5th.
Read Our Latest Analysis on TLRY
Tilray Trading Down 6.6 %
The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92. The company has a market capitalization of $1.53 billion, a price-to-earnings ratio of -4.50 and a beta of 2.36. The firm has a fifty day moving average price of $2.04 and a 200-day moving average price of $1.95.
Institutional Trading of Tilray
Institutional investors and hedge funds have recently made changes to their positions in the company. Clear Street Markets LLC bought a new stake in shares of Tilray during the 3rd quarter worth $25,000. Gainplan LLC acquired a new stake in Tilray in the fourth quarter valued at approximately $28,000. Simplicity Wealth LLC bought a new stake in shares of Tilray during the first quarter worth $28,000. RPO LLC bought a new stake in Tilray during the 4th quarter worth $28,000. Finally, Great Valley Advisor Group Inc. acquired a new position in shares of Tilray in the third quarter valued at approximately $29,000. Institutional investors own 9.35% of the company's stock.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
See Also
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
